UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumors

The Journal of clinical investigation, 2014-05, Vol.124 (5), p.2246-2259

2014

Link zum Volltext

Verfügbarkeit prüfen

Adoptive cell transfer: a clinical path to effective cancer immunotherapy

Nature reviews. Cancer, 2008-04, Vol.8 (4), p.299-308

2008

Link zum Volltext

Verfügbarkeit prüfen

Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1

Journal of clinical oncology, 2011-03, Vol.29 (7), p.917-924

2011

Link zum Volltext

Verfügbarkeit prüfen

Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens

Journal of clinical oncology, 2008-11, Vol.26 (32), p.5233-5239

2008

Link zum Volltext

Verfügbarkeit prüfen

Cancer Regression in Patients with Metastatic Melanoma after the Transfer of Autologous Antitumor Lymphocytes

Proceedings of the National Academy of Sciences - PNAS, 2004-10, Vol.101 (Suppl 2), p.14639-14645

2004

Link zum Volltext

Verfügbarkeit prüfen

Randomized Selection Design Trial Evaluating CD8+-Enriched Versus Unselected Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy for Patients With Melanoma

Journal of clinical oncology, 2013-06, Vol.31 (17), p.2152-2159

2013

Link zum Volltext

Verfügbarkeit prüfen

Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes

Science (American Association for the Advancement of Science), 2006-10, Vol.314 (5796), p.126-129

2006

Link zum Volltext

Verfügbarkeit prüfen

CD8+ Enriched Young Tumor Infiltrating Lymphocytes Can Mediate Regression of Metastatic Melanoma

Clinical cancer research, 2010-12, Vol.16 (24), p.6122-6131

2010

Link zum Volltext

Verfügbarkeit prüfen

Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma

Journal of clinical oncology, 2005-04, Vol.23 (10), p.2346-2357

2005

Link zum Volltext

Verfügbarkeit prüfen

Single-cell multiplexed cytokine profiling of CD19 CAR-T cells reveals a diverse landscape of polyfunctional antigen-specific response

Journal for immunotherapy of cancer, 2017-11, Vol.5 (1), p.85-16, Article 85

2017

Link zum Volltext

Verfügbarkeit prüfen

Gene Transfer of Tumor-Reactive TCR Confers Both High Avidity and Tumor Reactivity to Nonreactive Peripheral Blood Mononuclear Cells and Tumor-Infiltrating Lymphocytes

Journal of Immunology, 2006-11, Vol.177 (9), p.6548-6559

2006

Link zum Volltext

Verfügbarkeit prüfen

Adoptive immunotherapy for cancer: harnessing the T cell response

Nature reviews. Immunology, 2012-04, Vol.12 (4), p.269

2012

Link zum Volltext

Verfügbarkeit prüfen

Minimally cultured tumor-infiltrating lymphocytes display optimal characteristics for adoptive cell therapy

Journal of immunotherapy, 2008-10, Vol.31 (8), p.742-751

2008

Link zum Volltext

Verfügbarkeit prüfen

Adoptive cell therapy for patients with melanoma, using tumor-infiltrating lymphocytes genetically engineered to secrete interleukin-2

Human gene therapy, 2008-05, Vol.19 (5), p.496

2008

Link zum Volltext

Verfügbarkeit prüfen

Simplified method of the growth of human tumor infiltrating lymphocytes in gas-permeable flasks to numbers needed for patient treatment

Journal of immunotherapy (1997), 2012-04, Vol.35 (3), p.283

2012

Link zum Volltext

Verfügbarkeit prüfen

Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients

Journal of immunotherapy (1997), 2003-07, Vol.26 (4), p.332

2003

Link zum Volltext

Verfügbarkeit prüfen

Clinical scale rapid expansion of lymphocytes for adoptive cell transfer therapy in the WAVE® bioreactor

Journal of translational medicine, 2012-04, Vol.10 (1), p.69-69, Article 69

2012

Link zum Volltext

Verfügbarkeit prüfen

Persistence of CTL clones targeting melanocyte differentiation antigens was insufficient to mediate significant melanoma regression in humans

Clinical cancer research, 2015-02, Vol.21 (3), p.534-543

2015

Link zum Volltext

Verfügbarkeit prüfen

Signaling via a CD28/CD40 chimeric costimulatory antigen receptor (CoStAR™), targeting folate receptor alpha, enhances T cell activity and augments tumor reactivity of tumor infiltrating lymphocytes

Frontiers in immunology, 2023, Vol.14, p.1256491-1256491

2023

Link zum Volltext

Verfügbarkeit prüfen

Adoptive cell therapy for the treatment of patients with metastatic melanoma

Current opinion in immunology, 2009-04, Vol.21 (2), p.233-240

2009

Link zum Volltext

Verfügbarkeit prüfen

Tumor infiltrating lymphocyte therapy for metastatic melanoma: analysis of tumors resected for TIL

Journal of immunotherapy, 2010-10, Vol.33 (8), p.840-847

2010

Link zum Volltext

Verfügbarkeit prüfen

TIL therapy broadens the tumor-reactive CD8+ T cell compartment in melanoma patients

Oncoimmunology, 2012-07, Vol.1 (4), p.409-418

2012

Link zum Volltext

Verfügbarkeit prüfen

Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer

Science (American Association for the Advancement of Science), 2014-05, Vol.344 (6184), p.641-645

2014

Link zum Volltext

Verfügbarkeit prüfen

Adoptive Transfer of Autologous Natural Killer Cells Leads to High Levels of Circulating Natural Killer Cells but Does Not Mediate Tumor Regression

Clinical cancer research, 2011-10, Vol.17 (19), p.6287-6297

2011

Link zum Volltext

Verfügbarkeit prüfen

Tumor antigen–specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired

Blood, 2009-08, Vol.114 (8), p.1537-1544

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 295

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(275)
Mit Volltextzugriff
(244)

Publikationsform

Sprache

Englisch
(294)
Japanisch
(34)
Deutsch
(1)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(218)
Life Sciences & Biomedicine
(182)
Humans
(157)
Female
(90)
Male
(86)
Biological And Medical Sciences
(68)
Adult
(64)
Middle Aged
(63)
Medical Sciences
(62)
Oncology
(51)
Melanoma - Therapy
(49)
Melanoma - Immunology
(47)
Immunology
(44)
Animals
(38)
Aged
(37)
Lymphocytes, Tumor-Infiltrating - Immunology
(36)
Immunotherapy
(34)
Medicine, Research & Experimental
(33)
Research & Experimental Medicine
(33)
Melanoma
(30)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Immunotherapy
(19)
The Journal Of Immunology
(17)
Blood
(16)
Clinical Cancer Research
(10)
Journal Of Clinical Oncology
(10)
Pediatrics
(10)
Materials Science Forum
(8)
Circulation
(5)
Gastroenterology
(5)
The Journal Of Clinical Investigation
(5)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumors

Adoptive cell transfer: a clinical path to effective cancer immunotherapy

Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1

Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens

Cancer Regression in Patients with Metastatic Melanoma after the Transfer of Autologous Antitumor Lymphocytes

Randomized Selection Design Trial Evaluating CD8+-Enriched Versus Unselected Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy for Patients With Melanoma

Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes

CD8+ Enriched Young Tumor Infiltrating Lymphocytes Can Mediate Regression of Metastatic Melanoma

Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma

Single-cell multiplexed cytokine profiling of CD19 CAR-T cells reveals a diverse landscape of polyfunctional antigen-specific response

Gene Transfer of Tumor-Reactive TCR Confers Both High Avidity and Tumor Reactivity to Nonreactive Peripheral Blood Mononuclear Cells and Tumor-Infiltrating Lymphocytes

Adoptive immunotherapy for cancer: harnessing the T cell response

Minimally cultured tumor-infiltrating lymphocytes display optimal characteristics for adoptive cell therapy

Adoptive cell therapy for patients with melanoma, using tumor-infiltrating lymphocytes genetically engineered to secrete interleukin-2

Simplified method of the growth of human tumor infiltrating lymphocytes in gas-permeable flasks to numbers needed for patient treatment

Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients

Clinical scale rapid expansion of lymphocytes for adoptive cell transfer therapy in the WAVE® bioreactor

Persistence of CTL clones targeting melanocyte differentiation antigens was insufficient to mediate significant melanoma regression in humans

Signaling via a CD28/CD40 chimeric costimulatory antigen receptor (CoStAR™), targeting folate receptor alpha, enhances T cell activity and augments tumor reactivity of tumor infiltrating lymphocytes

Adoptive cell therapy for the treatment of patients with metastatic melanoma

Tumor infiltrating lymphocyte therapy for metastatic melanoma: analysis of tumors resected for TIL

TIL therapy broadens the tumor-reactive CD8+ T cell compartment in melanoma patients

Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer

Adoptive Transfer of Autologous Natural Killer Cells Leads to High Levels of Circulating Natural Killer Cells but Does Not Mediate Tumor Regression

Tumor antigen–specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired

Suchergebnisse filtern